Skip to main content

Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis

  • H. JIN (a1) (a2), Y. ZHAO (a2), X. ZHANG (a3), B. WANG (a3) and P. LIU (a2)...

It is of great concern that pregnant women with acute viral hepatitis (AVH) type E have serious consequences. This study aimed to estimate the case-fatality risk (CFR) and potential risk factors of pregnant women with AVH type E. We searched the PubMed, EMBASE, and Web of Science databases for studies containing data on CFR in pregnancy with AVH type E. A pooled estimate of CFR was calculated using a random-effects model. Potential sources of heterogeneity were explored using subgroup analysis, sensitivity analysis, and meta-regression. We identified 47 eligible studies with a total African and Asian population of 3968 individuals. The pooled CFRs of maternal and fetal outcomes were 20·8% [95% confidence interval (CI) 16·6–25·3] and 34·2% (95% CI 26·0–43·0), respectively. Compared with these, the pooled CFR was highest (61·2%) in women with fulminant hepatic failure (FHF). Community-based surveys had lower pooled CFR (12·2%, 95% CI 9·2–15·6) and heterogeneity (25·8%, 95% CI 20·1–32·0) than hospital-based surveys. Univariate analysis showed that hospital-based surveying (P = 0·007), and patients in the third trimester of pregnancy or with FHF (P < 0·05), were significantly associated with CFR. Intrauterine fetal mortality (27·0%) was statistically higher than neonatal mortality (3·9%). Control measures for HEV infection would reduce feto-maternal mortality in Asia and Africa.

Corresponding author
*Author for correspondence: Mr H. Jin, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China. (Email:
Hide All
1. Rein, DB, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55: 988997.
2. Teo, CG. Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E. Epidemiology and Infection 2012; 140: 767787.
3. Kourtis, AP, et al. Pregnancy and infection. New England Journal of Medicine 2014; 370: 22112218.
4. Labrique, AB, et al. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerging Infectious Diseases 2012; 18: 14011404.
5. Atkins, KE, et al. Under-reporting and case fatality estimates for emerging epidemics. British Medical Journal 2015; 350: h1115.
6. Pelat, C, et al. Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach. American Journal of Epidemiology 2014; 180: 10361046.
7. von Elm, E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 14531457.
8. Ciapponi, A, et al. Epidemiology of pediatric pneumococcal meningitis and bacteremia in Latin America and the Caribbean: a systematic review and meta-analysis. Pediatric Infectious Disease Journal 2014; 33: 971978.
9. Beijer, U, et al. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infectious Diseases 2012; 12: 859870.
10. Viechtbauer, W. Conducting meta-analyses in R with the metafor package. Journal of Stata Software 2010; 36: 148.
11. Patra, S, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Annals of Internal Medicine 2007; 147: 2833.
12. Shinde, N, et al. Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy. Annals Medicine Health Science Research 2014; 4: S133S139.
13. Mirazo, S, et al. Transmission, diagnosis, and management of hepatitis E: an update. Journal of Hepatic Medicine: Evidence and Research 2014; 6: 4559.
14. Wong, JY, et al. Hospitalization fatality risk of influenza A(H1N1)pdm09: a systematic review and meta-analysis. American Journal of Epidemiology 2015; 182: 294301.
15. Kumar, A, et al. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine 2014; 65: 95104.
16. Bose, PD, et al. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. Journal of Hepatology 2011; 54: 11071113.
17. Zhu, FC, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895902.
18. Wu, T, et al. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012; 55: 2038.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Jin supplementary material S1
Supplemental File

 Word (2.2 MB)
2.2 MB
Supplementary materials

Jin supplementary material S3
Supplemental File

 Word (779 KB)
779 KB
Supplementary materials

Jin supplementary material S2
Supplemental File

 Word (65 KB)
65 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed